These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11279874)

  • 1. Issues in antiretroviral therapy: when to start?
    Boyle BA
    AIDS Read; 2001 Feb; 11(2):66-70. PubMed ID: 11279874
    [No Abstract]   [Full Text] [Related]  

  • 2. The public health implications of HIV therapy.
    Ritsema TS
    JAAPA; 2002 Apr; 15(4):29-30, 33-4, 39. PubMed ID: 12012585
    [No Abstract]   [Full Text] [Related]  

  • 3. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV therapeutics in children and adults and their side effects.
    Laurence J
    AIDS Read; 2004 Jan; 14(1):6-7. PubMed ID: 14959697
    [No Abstract]   [Full Text] [Related]  

  • 5. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications & side effects. HAART and bones-mixed messages.
    TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
    [No Abstract]   [Full Text] [Related]  

  • 11. Compliance with antiretroviral regimens.
    Laurence J
    AIDS Read; 2001 Apr; 11(4):177, 181. PubMed ID: 11392675
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
    Voirin N; Routy JP; Smith D; Baratin D; Trépo C; Cotte L; Touraine JL; Livrozet JM; Cooper DA; Ritter J; André P; Vanhems P
    HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for kidney transplantation in patients with HIV disease.
    Bhagani S; Sweny P; Brook G;
    HIV Med; 2006 Apr; 7(3):133-9. PubMed ID: 16494626
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of CD4 count, viral load and highly active antiretroviral therapy in HIV-associated thrombotic thrombocytopenic purpura (TTP).
    Hill QA; Minton J
    Sex Transm Infect; 2012 Feb; 88(1):38-9. PubMed ID: 22045846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005).
    ;
    Chin Med J (Engl); 2006 Oct; 119(19):1589-608. PubMed ID: 17042972
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating HIV infection and AIDS in women.
    Squires KE
    AIDS Read; 2003 May; 13(5):228-34, 239-40. PubMed ID: 12800826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Highly active antiretroviral therapy].
    Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):58-61. PubMed ID: 19769079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.